Cargando…
Danggui-Shaoyao-San Attenuates Cognitive Impairment via the Microbiota–Gut–Brain Axis With Regulation of Lipid Metabolism in Scopolamine-Induced Amnesia
Danggui-Shaoyao-San (DSS) has a long history of being used as a traditional medicine (TCM) and has been reported to show therapeutic effects in alleviating the symptoms of cognitive impairment. The purpose of this study was to investigate whether DSS treatment attenuates cognitive impairment via the...
Autores principales: | Liu, Piaoxue, Zhou, Xun, Zhang, Haoran, Wang, Rui, Wu, Xiaolang, Jian, Wenxuan, Li, Weirong, Yuan, Dongsheng, Wang, Qi, Zhao, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9162091/ https://www.ncbi.nlm.nih.gov/pubmed/35664001 http://dx.doi.org/10.3389/fimmu.2022.796542 |
Ejemplares similares
-
Systems pharmacology-based approach to investigate the mechanisms of Danggui-Shaoyao-san prescription for treatment of Alzheimer’s disease
por: Wu, Qihui, et al.
Publicado: (2020) -
Danggui Shaoyao San Ameliorates Renal Fibrosis via Regulation of Hypoxia and Autophagy
por: Zhang, Meng-yun, et al.
Publicado: (2019) -
Experimental Study on Danggui Shaoyao San Improving Renal Fibrosis by Promoting Autophagy
por: Fan, Lian, et al.
Publicado: (2022) -
Danggui-Shaoyao-San for dementia: A PRISMA-compliant systematic review and meta-analysis
por: Kim, Yunna, et al.
Publicado: (2020) -
Network Pharmacology Approach to Investigate the Mechanism of Danggui-Shaoyao-San against Diabetic Kidney Disease
por: Chen, Yulian, et al.
Publicado: (2023)